Malignant Hypertension and Acute Loss of Vision In A Patient With History of Pre-eclampsia

Ghani Siti-Ilyana, Ang Wen-Jeat, Wan-Hitam Wan-Hazabbah, Embong Zunaina

Abstract


Pre-eclampsia may have an impact on women’s health beyond their pregnancies and has been associated with increased risks for future hypertension and cardiovascular disease. We report a case of a patient with history of pre-eclampsia and emergency caesarean section at 31 weeks of gestation due to impending eclampsia who defaulted follow up and presented with malignant hypertension and acute loss of vision 10 years later. A 34-year-old Malay female,  presented with generalized painless reduced vision of 5 days duration which was preceded by an intermittent headache for 1 months duration. She had a history of pre-eclampsia during her last childbirth 10 years ago and was not started on any antihypertensive medication as her blood pressure normalized 2 weeks post-delivery. Subsequently, she defaulted on her follow up. Visual acuity was counting finger at 1 meter in both eyes with no relative afferent pupillary defect. Funduscopy revealed bilateral grade IV hypertensive retinopathy with the presence of optic disc swelling and macular star. Optical coherence tomography showed bilateral sub-retinal fluid at the macula. Her blood pressure was 255/168 mmHg with other systemic examinations being normal. Ultrasonography of the kidneys showed the presence of bilateral renal parenchymal disease with elevation of serum urea and creatinine levels. Her blood pressure was controlled with triple oral antihypertensive agents. Her vision improved to 6/36 and 6/6 with a pinhole in both eyes and resolution of papilloedema and sub-retinal fluid at three  months follow-up. Patients with a history of pre-eclampsia must be closely monitored during the postpartum period. Even though her blood pressure was normalized, careful monitoring and long-term medical follow up plan must be clearly explained to the patient as she might develop chronic or essential hypertension afterward. Our patient most likely had essential hypertension superimposed with pre-eclampsia during her last pregnancy and currently presented with malignant hypertension due to undiagnosed chronic hypertension as she defaulted her medical follow up.


Keywords


Pre-eclampsia, Hypertensive retinopathy, Malignant hypertension

Full Text:

PDF

References


Jeyabalan A. Epidemiology of preeclampsia: Impact of obesity. Nutr Rev. 2013;71(0 1):10.1111/nure.12055. doi:10.1111/nure.12055.

Ananth CV, Keyes KM, Wapmer RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. Br Med J 2013;347: f6564.

Garovic VD, August P. Preeclampsia and the future risk of hypertension: The pregnant evidence. Curr Hypertens Resp 2013;15(2):10.1007/s11906-013-0329-4. doi:10.1007/s11906-013-0329-4.

Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens. 2010;28:1349–1355

Tranquilli AL. Introduction to ISSHP new classification of preeclampsia. Pregnancy Hypertens. 2013;3(2):58-9. doi: 10.1016/j.preghy.2013.04.006.

Mounier-Vehier C, Madika AL, Boudghène-Stambouli F, et al. Hypertension in pregnancy and future maternal health. Presse Med. 2016: 45(7-8 Pt 1):659-66. doi:10.1016/j.lpm.2016.05.017.

Nakimuli A, Elliott AM, Kaleebu P, et al. Hypertension persisting after pre-eclampsia: A prospective cohort study at Mulago Hospital, Uganda. PLoS ONE 2013;8(12):e85273. doi:10.1371/journal.pone.0085273.

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-474. doi:10.2147/VHRM.S20181.

Behrens I, Basit S, Melbye M, Lykke JA, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. Br Med J. 2017:12;358:j3078. doi: 10.1136/bmj.j3078.

Al-Bannay R, Husain AA. Hypertensive crisis. Clinical presentation, comorbidities, and target organ involvement. Saudi Med J 2010; 30: 916–920.

Ahn SJ, Woo SJ, Park KH. Retinal and choroidal changes with severe hypertension and their association with visual outcome. Invest Ophthalmol Vis Sci. 2014;55(12):7775-85. doi: 10.1167/iovs.14-14915.

Browning AC, Mengher LS, Gregson RM, et al. Visual outcome of malignant hypertension in young people. Arch Dis Child 2001 Nov;85(5):401-403.




Copyright (c) 2018 Journal of Biomedical and Clinical Sciences (JBCS)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

 

Flag Counter           

                     

                                              Copyright © 2016 AMDI Publisher, Universiti Sains Malaysia.
Disclaimer : This website has been updated to the best of our knowledge to be accurate. However, Universiti Sains Malaysia shall not be liable for any loss or damage caused by the usage of any information obtained from this web site.
                                            Best viewed: Mozilla Firefox 4.0 & Google Chrome at 1024 × 768 resolution.